Sevelamer hydrochloride

• Post Date:

  Jan 09,2018

• Expiry Date:

  Jul 08,2018

• Detailed Description:

  Cas No. :152751-57-0 Quantity: mass in stockKilograms
  Specs:white powder
  Price:negotiable USD Kilograms
  Payment Method: T/T, Western Union,Moneygram and Bitcoin.
  Description:
  
  Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals.
  
  Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
  
  
  
  Use:
  
  Sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Sevelamer works by holding onto phosphate from the diet so that it can pass out of your body.
  
  
  How to use sevelamer HCl
  
  Take this medication by mouth, usually 3 times daily with meals or as directed by your doctor. Swallow the tablet whole. Do not crush, chew, or split the tablet. Dosage is based on your medical condition, any other medications you take to lower your

• CAS Registry Number:

  152751-57-0

• Synonyms:

  ;Sevelemar;2-Propen-1-amine polymer with (chloromethyl)oxirane hydrochloride;prop-2-en-1-amine - 2-(chloromethyl)oxirane hydrochloride (1:1:1);prop-2-en-1-amine - 2-(chloromethyl)oxirane (1:1);Sevelamer hydrochloride;

• Molecular Formula:

  C₆H₁₂ClNO

• Molecular Weight:

  149.6186

• Molecular Structure:

  

• Company:

  Hengyang Desen Biotechnology Co., Ltd.     [ China ]        

• Contact:

  ava

• Tel:

  86-18908446905

• Fax:

• Email:

  ava@ycgmp.com